Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearch
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
euroAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Pharmacotherapy change patterns after fragility fracture in patients receiving bone-active medication: a fracture liaison service quality improvement cohort study

- Ansari H. , et al.

2. PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis

- Beaudart C. , et al.

3. Open Reduction Internal Fixation vs Primary Arthrodesis for Lisfranc Fracture-Dislocations: A Cost Analysis

- Ochuba A. , et al.

4. Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA

- Eisman J.A. , et al.

5. Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis

- Thomasius F. , et al.

6. The effect of treatment and bone metabolic factors on fracture incidence in patients with thalassemia-induced osteoporosis: An observational study

- Tsartsalis A.N. , et al.